AEON Biopharma, Inc. (NYSE AMERICAN: AEON)
$0.1153
-0.0117 ( -4.55% ) 2.9M
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
Market Data
Open
$0.1153
Previous close
$0.1270
Volume
2.9M
Market cap
$10.16M
Day range
$0.1150 - $0.1340
52 week range
$0.1150 - $17.1700
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | May 16, 2024 |
| ars/a | Annual reports | 1 | May 14, 2024 |
| 10-q | Quarterly Reports | 78 | May 14, 2024 |
| 8-k | 8K-related | 16 | May 14, 2024 |